Business Development
As a leading biopharma company, partnering is a key priority for us and plays a critical role in our strategy. We seek to combine external innovative science and technologies with our internal capabilities and expertise to transform patients’ lives through science. We are active across the entire business development spectrum and all our collaborations are essential to evolving our portfolio and driving our long-term sustainability.
 |
12/20 |
 |
60% |
 |
300+ |
Working together
We have a distinct and decisive approach to partnering that leverages the best of Bristol Myers Squibb and the best of our partners to speed transformational medicines to patients. We strive to be a partner of choice and establish a creative and customized approach for each agreement.
Business Development leadership team Learn more >
We are open to a wide range of partnership opportunities focused on transformational science and we are committed to being a leading biopharma partner.
Elizabeth Mily, Executive Vice President Strategy and Business Development
Learn more about our fully dedicated group of experienced leaders that serve as the primary point of contact to foster and strengthen the relationship between Bristol Myers Squibb and partners.
Every day, each of us works to improve outcomes for patients fighting serious diseases. Together, we're building a better future for each other and the patients who need us most.